Read + Share
Amedeo Smart
Independent Medical Education
Alatrach M, Laichuthai N, Martinez R, Agyin C, et al. Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors. Diabetes 2020;69:681-688.PMID: 31915153
Email
LinkedIn
Facebook
Twitter
Privacy Policy